Checkmate Pharmaceuticals, Inc.
Biotechnology company · Cambridge, Massachusetts, United States
Checkmate Pharmaceuticals, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2015. It has reported private securities offerings to the US SEC, most recently $85 million sold in a notice filed in 2020.
Checkmate Pharmaceuticals at a glance
What does Checkmate Pharmaceuticals do?
Private fundraising reported to the SEC
10 Form D notices; the most recent reported $85.1 million sold (2020).
Frequently asked questions about Checkmate Pharmaceuticals
Where is Checkmate Pharmaceuticals headquartered?
Checkmate Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Checkmate Pharmaceuticals do?
Checkmate Pharmaceuticals, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
When was Checkmate Pharmaceuticals founded?
The earliest incorporation on record for Checkmate Pharmaceuticals, Inc. is in 2015, according to public company registers.
Similar companies
- Editas Medicine, Inc.Cambridge, Massachusetts, United States
- Moderna, Inc.Cambridge, Massachusetts, United States
- Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
- Beam Therapeutics Inc.Cambridge, Massachusetts, United States
- Genzyme CorpCambridge, Massachusetts, United States
- Neutrolis Inc.Cambridge, Massachusetts, United States
- Biogen Inc.Cambridge, Massachusetts, United States
- Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences